Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.62B |
| 2 |
Apple
AAPL
|
+$747M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$655M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$427M |
| 5 |
Walt Disney
DIS
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$2.63B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 3 |
Yum! Brands
YUM
|
+$734M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$558M |
| 5 |
Visa
V
|
+$398M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.59% |
| 2 | Technology | 8.45% |
| 3 | Healthcare | 7.6% |
| 4 | Consumer Discretionary | 6.86% |
| 5 | Energy | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
Invesco Biotechnology & Genome ETF
PBE
$284M
| $2.56M | ﹤0.01% |
66,771
+479
| +0.7% | +$18.6K |
|
|
BMCH
3227
DELISTED
BMC Stock Holdings, Inc
BMCH
| $2.55M | ﹤0.01% |
153,617
+61,622
| +67% | +$903K |
|
3228
Ceco Environmental
CECO
$3.99B
| $2.55M | ﹤0.01% |
410,541
-945,077
| -70% | -$6.4M |
|
3229
PUT
MannKind Corp
MNKD
$1.17B
| $2.55M | ﹤0.01% |
316,640
-311,700
| -50% | -$1.78M |
|
|
PTLA
3230
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $2.55M | ﹤0.01% |
124,846
+57,307
| +85% | +$1.82M |
|
|
AMTG
3231
DELISTED
APOLLO RESIDENTIAL MTG INC COM STK
AMTG
| $2.55M | ﹤0.01% |
189,788
+144,098
| +315% | +$1.68M |
|
|
TBRG
3232
DELISTED
TruBridge
TBRG
| $2.54M | ﹤0.01% |
48,805
+11,996
| +33% | +$635K |
|
|
SAGE
3233
DELISTED
Sage Therapeutics
SAGE
| $2.54M | ﹤0.01% |
79,324
+47,413
| +149% | +$1.67M |
|
3234
PUT
Hershey
HSY
$35.7B
| $2.54M | ﹤0.01% |
27,600
-34,700
| -56% | -$3.1M |
|
3235
Calix
CALX
$2.35B
| $2.54M | ﹤0.01% |
358,123
-11,497
| -3% | -$81.2K |
|
|
SWN
3236
PUT
DELISTED
Southwestern Energy Company
SWN
| $2.54M | ﹤0.01% |
314,700
+88,100
| +39% | +$675K |
|
|
RWT
3237
Redwood Trust
RWT
$580M
| $2.54M | ﹤0.01% |
194,003
-80,260
| -29% | -$937K |
|
|
CSFL
3238
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $2.53M | ﹤0.01% |
170,066
-19,143
| -10% | -$276K |
|
3239
Pearson
PSO
$10.1B
| $2.52M | ﹤0.01% |
201,286
+156,669
| +351% | +$1.79M |
|
|
VIAB
3240
PUT
DELISTED
Viacom Inc. Class B
VIAB
| $2.52M | ﹤0.01% |
61,100
-144,400
| -70% | -$5.74M |
|
3241
PUT
BHP
BHP
$212B
| $2.52M | ﹤0.01% |
109,073
-26,120
| -19% | -$553K |
|
3242
CALL
Opko Health
OPK
$978M
| $2.52M | ﹤0.01% |
242,100
-43,300
| -15% | -$396K |
|
|
FNSR
3243
DELISTED
Finisar Corp
FNSR
| $2.51M | ﹤0.01% |
137,627
-17,493
| -11% | -$252K |
|
|
NCI
3244
DELISTED
Navigant Consulting, Inc.
NCI
| $2.5M | ﹤0.01% |
158,067
+50,455
| +47% | +$772K |
|
3245
CALL
ProShares Ultra Silver
AGQ
$1.14B
| $2.5M | ﹤0.01% |
76,100
+3,400
| +5% | +$106K |
|
3246
PUT
Baxter International
BAX
$14.5B
| $2.5M | ﹤0.01% |
60,800
-55,900
| -48% | -$2.13M |
|
|
AUD
3247
DELISTED
Audacy, Inc.
AUD
| $2.49M | ﹤0.01% |
235,633
-36,896
| -14% | -$392K |
|
3248
PUT
Insulet
PODD
$11.8B
| $2.49M | ﹤0.01% |
75,000
+29,500
| +65% | +$926K |
|
3249
CALL
PNC Financial Services
PNC
$100B
| $2.49M | ﹤0.01% |
29,400
-30,100
| -51% | -$2.56M |
|
3250
PUT
Lam Research
LRCX
$369B
| $2.48M | ﹤0.01% |
300,000
-2,786,000
| -90% | -$20.3M |
|
Similar funds
Goldman Sachs's Q1 2016 Portfolio in Review
As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.
- Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
- Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
- Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
- Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
- Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
- Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
- Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.
Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.